47.73.Z - Retail sale of pharmaceutical products
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
47.91.Z - Intermediary retail sale, non-specialized
49.41.Z - Road freight transport
63.11.Z - Services related to computing infrastructure, data processing, website management (hosting), and other information services
63.12.Z - Services related to computing infrastructure, data processing, website management (hosting), and other information services
73.20.Z - Market research and public opinion polling
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 0,4 | 0,5 | 0,6 | 19 |
EBITDA | 0,4 | 0,5 | 0,6 | 20,6 |
Short time liabilities | 0,5 | 0,6 | 0,7 | 24 |
Equity capital | 0,3 | 0,3 | 0,5 | 45,5 |
Operating profit (EBIT) | 0,3 | 0,5 | 0,6 | 19 |
Assets | 0,8 | 0,9 | 1,2 | 31,9 |
Net profit (loss) | 0,4 | 0,5 | 0,6 | 19,6 |
Cash | 0,1 | 0,1 | 0,2 | 19,1 |
Net income from sale | 5,9 | 6,9 | 7,5 | 9,3 |
Liabilities and provisions for liabilities | 0,5 | 0,6 | 0,7 | 23,9 |
Working assets | 0,7 | 0,8 | 1,1 | 34,9 |
Depreciation | 0 | 0 | 0 | 158,8 |
% | % | % | p.p. | |
Profitability of capital | 136,8 | 139 | 114,2 | -24,8 |
Equity capital to total assets | 33,6 | 37 | 40,8 | 3,8 |
Gross profit margin | 6,8 | 7,6 | 8,3 | 0,7 |
EBITDA Margin | 6,2 | 7,7 | 8,5 | 0,8 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 33 | 30 | 34 | 4 |
Current financial liquidity indicator | 1.3007582426071167 | 1.398273229598999 | 1.5230294466018677 | 0,1 |
Net dept to EBITDA | -0.1968257874250412 | -0.26533740758895874 | -0.27976566553115845 | 0 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane